TY  - JOUR
AU  - Jara-Palomares, Luis
AU  - Solier-Lopez, Aurora
AU  - Elias-Hernandez, Teresa
AU  - Asensio-Cruz, Maria Isabel
AU  - Blasco-Esquivias, Isabel
AU  - Sanchez-Lopez, Veronica
AU  - de la Borbolla, Maria Rodriguez
AU  - Arellano-Orden, Elena
AU  - Suarez-Valdivia, Lionel
AU  - Marin-Romero, Samira
AU  - Marin-Barrera, Lucia
AU  - Ruiz-Garcia, Aranzazu
AU  - Montero-Romero, Emilio
AU  - Navarro-Herrero, Silvia
AU  - Lopez-Campos, Jose Luis
AU  - Serrano-Gotarredona, Maria Pilar
AU  - Praena-Fernandez, Juan Manuel
AU  - Sanchez-Diaz, Jose Maria
AU  - Otero-Candelera, Remedios
PY  - 2018
DO  - 10.1038/s41416-018-0269-5
UR  - http://hdl.handle.net/10668/13079
T2  - British journal of cancer
AB  - Optimal duration of anticoagulation for cancer-associated thrombosis (CAT) remains unclear. This study assessed D-dimer (DD) and high-sensitivity C-reactive protein (hs-CRP) levels after the withdrawal of anticoagulation treatment to predict the risk...
LA  - en
KW  - Anticoagulants
KW  - C-Reactive Protein
KW  - Drug Administration Schedule
KW  - Female
KW  - Fibrin Fibrinogen Degradation Products
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - Prospective Studies
KW  - Recurrence
KW  - Risk Assessment
KW  - Risk Factors
KW  - Secondary Prevention
KW  - Venous Thromboembolism
KW  - Venous Thrombosis
KW  - Withholding Treatment
TI  - D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis.
TY  - research article
VL  - 119
ER  -